Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision label changes from 'Revision: v3.6.2' to 'Revision: v3.6.3', indicating a new site release.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page footer now displays Revision: v3.6.2, replacing the previous v3.6.0. This reflects an update to the page's version metadata.SummaryDifference0.0%

- Check32 days agoChange DetectedThe study record now indicates that it is no longer recruiting participants, clarifying that enrollment has ceased. A new revision marker v3.6.0 was added and the previous marker v3.5.5 was removed, updating the version history of the record.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page's revision metadata updated from v3.5.4 to v3.5.5, indicating a new version of the page that tracks historical edits.SummaryDifference0.0%

- Check60 days agoChange DetectedThe record history now displays Revision: v3.5.4, replacing Revision: v3.5.3. This signals a new release version of the history interface.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.5.3 now appears, replacing Revision: v3.5.2. This indicates a small backend or template update without altering the study data or visible content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.